• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Generex Biotechnology Corp

+ Add to Watchlist


0.0195 USD 0.0003 1.56%

As of 20:10:00 ET on 11/25/2014.

Snapshot for Generex Biotechnology Corp (GNBT)

Open: 0.0185 Day's Range: 0.0185 - 0.0195 Volume: 1,135,800
Previous Close: 0.0192 52wk Range: 0.0161 - 0.0560 1-Yr Rtn: -31.28%

Stock Chart for GNBT

No chart data available.
  • GNBT:US 0.0188
  • 1D
  • 1M
  • 1Y
Interactive GNBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GNBT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0080
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 15.18
Shares Outstanding (M) 778.51
30 Day Average Volume 2,142,898
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GNBT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for GNBT

Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.

Mark A FletcherPresident/Exec VP/CEOStephen FellowsChief Financial Officer
David A BrusegardCOO/SecretaryEric Von HofeVice President
More Company Profile & Key Executives for GNBT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • GNBT News

  • Industry News

No stories found
No stories found
Sponsored Links
sec ||= nil